110460-18-9

Basic information

• Product Name: 3-OXO-6-PHENYL-3,4-DIHYDROPYRAZINE-2-CARBOXYLIC ACID
• Synonyms: 3-OXO-6-PHENYL-3,4-DIHYDROPYRAZINE-2-CARBOXYLIC ACID
• CAS NO: 110460-18-9
• Molecular Formula: C₁₁H₈N₂O₃
• Molecular Weight: 216.19
• Mol File: 110460-18-9.mol
• Article Data: 1

Chemical Properties

• Melting Point: 220 °C
• Appearance: /
• Density: 1.40±0.1 g/cm3(Predicted)
• PKA: 0.30±0.20(Predicted)
• CAS DataBase Reference: 3-OXO-6-PHENYL-3,4-DIHYDROPYRAZINE-2-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-OXO-6-PHENYL-3,4-DIHYDROPYRAZINE-2-CARBOXYLIC ACID(110460-18-9)
• EPA Substance Registry System: 3-OXO-6-PHENYL-3,4-DIHYDROPYRAZINE-2-CARBOXYLIC ACID(110460-18-9)

Safety Data

• Hazardous Substances Data: 110460-18-9(Hazardous Substances Data)

Upstream product

• 1374850-08-4 C₁₂H₁₀N₂O₃ 
• 1503-42-0 methyl 3-amino-6-phenyl-2-pyrazine carboxylate 
• 6966-01-4 methyl 3-amino-6-bromopyrazine-2-carboxylate 
• 98-80-6 phenylboronic acid 
• 100518-37-4 2,6-diamino-5-(2-nitro-1-phenyl-ethylLiDenamino)-3H-pyrimidin-4-one 
• 113120-69-7 2-amino-3-carbamoyl-5-phenylpyrazine 
• 25846-86-0 6-(phenyl)pterin 
• 84066-21-7 3-amino-6-phenyl-2-pyrazine carboxylic acid 

Relevant articles and documents

INHIBITORS OF FATTY ACID BINDING PROTEIN

The present invention relates to novel heterocyclic compounds as Fatty Acid Binding Protein (“FABP”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose.